✨
AI Summary
- Autoimmune CAR T therapy is advancing rapidly, requiring a new patient-focused strategy.
- Discussed benefit-risk, patient burden of conditioning, apheresis, and monitoring needs.
- Rethinking clinical trial endpoints is crucial for autoimmune CAR T development.
Guests on This Episode
PT
Panteli Theocharous
1 podcast appearance